Raymond James Financial Services Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.93M | Buy |
36,387
+1,164
| +3% | +$127K | 0.01% | 1359 |
|
|
2024
Q2 | $3.82M | Sell |
35,223
-1,954
| -5% | -$230K | 0.01% | 1302 |
|
|
2024
Q1 | $4.91M | Buy |
37,177
+625
| +2% | +$78.1K | 0.01% | 1148 |
|
|
2023
Q4 | $4.45M | Buy |
36,552
+2,298
| +7% | +$256K | 0.01% | 1147 |
|
|
2023
Q3 | $3.84M | Buy |
34,254
+3,624
| +12% | +$460K | 0.01% | 1156 |
|
|
2023
Q2 | $4.46M | Buy |
30,630
+818
| +3% | +$111K | 0.01% | 1083 |
|
|
2023
Q1 | $3.85M | Buy |
29,812
+168
| +0.6% | +$21.1K | 0.01% | 1122 |
|
|
2022
Q4 | $3.78M | Sell |
29,644
-1,538
| -5% | -$178K | 0.01% | 1105 |
|
|
2022
Q3 | $3.26M | Buy |
31,182
+467
| +2% | +$51.2K | 0.01% | 1152 |
|
|
2022
Q2 | $3.23M | Sell |
30,715
-3,636
| -11% | -$431K | 0.01% | 1162 |
|
|
2022
Q1 | $4.39M | Sell |
34,351
-9,696
| -22% | -$1.17M | 0.01% | 1072 |
|
|
2021
Q4 | $5.43M | Sell |
44,047
-2,351
| -5% | -$308K | 0.01% | 974 |
|
|
2021
Q3 | $6.59M | Sell |
46,398
-13,799
| -23% | -$2.03M | 0.01% | 830 |
|
|
2021
Q2 | $9.4M | Buy |
60,197
+1,496
| +3% | +$242K | 0.02% | 679 |
|
|
2021
Q1 | $9.12M | Buy |
58,701
+1,615
| +3% | +$250K | 0.02% | 664 |
|
|
2020
Q4 | $8.54M | Sell |
57,086
-48,576
| -46% | -$6.86M | 0.02% | 624 |
|
|
2020
Q3 | $14M | Sell |
105,662
-9,815
| -8% | -$1.28M | 0.04% | 401 |
|
|
2020
Q2 | $13.4M | Sell |
115,477
-6,478
| -5% | -$746K | 0.04% | 391 |
|
|
2020
Q1 | $12M | Buy |
121,955
+18,090
| +17% | +$2.37M | 0.05% | 329 |
|
|
2019
Q4 | $15.1M | Buy |
103,865
+81,560
| +366% | +$11.3M | 0.05% | 382 |
|
|
2019
Q3 | $2.97M | Sell |
22,305
-1,165
| -5% | -$150K | 0.01% | 906 |
|
|
2019
Q2 | $2.68M | Sell |
23,470
-244
| -1% | -$28.6K | 0.01% | 944 |
|
|
2019
Q1 | $2.94M | Buy |
23,714
+584
| +3% | +$66.4K | 0.01% | 876 |
|
|
2018
Q4 | $2.33M | Sell |
23,130
-305
| -1% | -$34.3K | 0.01% | 829 |
|
|
2018
Q3 | $2.99M | Buy |
23,435
+173
| +0.7% | +$20.6K | 0.01% | 867 |
|
|
2018
Q2 | $2.52M | Buy |
23,262
+736
| +3% | +$80.1K | 0.01% | 901 |
|
|
2018
Q1 | $2.38M | Sell |
22,526
-37
| -0.2% | -$4.3K | 0.01% | 845 |
|
|
2017
Q4 | $2.64M | Sell |
22,563
-1,032
| -4% | -$117K | 0.02% | 786 |
|
|
2017
Q3 | $2.68M | Buy |
23,595
+771
| +3% | +$89K | 0.02% | 786 |
|
|
2017
Q2 | $2.85M | Buy |
22,824
+848
| +4% | +$101K | 0.02% | 728 |
|
|
2017
Q1 | $2.6M | Buy |
21,976
+3,982
| +22% | +$451K | 0.02% | 714 |
|
|
2016
Q4 | $1.8M | Sell |
17,994
-36,254
| -67% | -$3.89M | 0.02% | 828 |
|
|
2016
Q3 | $6.85M | Buy |
54,248
+10,989
| +25% | +$1.36M | 0.06% | 343 |
|
|
2016
Q2 | $5.06M | Buy |
43,259
+31,784
| +277% | +$3.6M | 0.05% | 406 |
|
|
2016
Q1 | $1.19M | Sell |
11,475
-11,358
| -50% | -$1.1M | 0.01% | 826 |
|
|
2015
Q4 | $2.27M | Buy |
22,833
+3,546
| +18% | +$347K | 0.03% | 598 |
|
|
2015
Q3 | $1.76M | Buy |
+19,287
| New | +$1.93M | 0.03% | 566 |
|
Other funds holding ZBH
Raymond James Financial Services Advisors's ZBH Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its Zimmer Biomet (ZBH) stake by 3.3% in Q3 2024, buying an estimated $127K and bringing the position to 36,387 shares worth $3.93M. The position accounts for 0.01% of the portfolio, ranked #1359.
Raymond James Financial Services Advisors first reported a position in ZBH in Q3 2015 and has held it in 37 quarters since. The position peaked at $15.1M in Q4 2019. 983 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- Raymond James Financial Services Advisors held 36,387 shares of Zimmer Biomet worth $3.93M as of Q3 2024.
- Raymond James Financial Services Advisors bought 1,164 Zimmer Biomet shares in Q3 2024, an estimated $127K.
- Zimmer Biomet made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1359 holding.
- Raymond James Financial Services Advisors first reported a position in Zimmer Biomet in Q3 2015 and has held it in 37 quarters since.
- Raymond James Financial Services Advisors's Zimmer Biomet position peaked at $15.1M in Q4 2019.
- 983 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.